News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

PledPharma Today Announces That the MANAMI Study is Fully Recruited



4/18/2013 11:29:08 AM

Stockholm, 2013-04-18 13:29 CEST (GLOBE NEWSWIRE) -- In the ongoing small investigator initiated clinical phase IIa trial MANAMI, which examines a PLED substance (mangafodipir) in patients with acute myocardial infarction undergoing coronary angioplasty (PCI), all twenty patients are now included. After analyzing the data, we expect to announce results during 2013.

Read at GlobeNewswire


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES